TreeWAS – Variant ID: rs112232665

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
# Top node	1.000	0.000
Chapter II Neoplasms	1.000	0.000
Chapter XXI Factors influencing health status and contact with health services	1.000	0.000
Z85 Personal history of malignant neoplasm	0.999	0.001
Z80-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status	0.999	0.001
Z85.8 Personal history of malignant neoplasms of other organs and systems	0.998	0.002
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.996	0.004
Chapter I Certain infectious and parasitic diseases	0.995	0.005
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.995	0.005
Z40-Z54 Persons encountering health services for specific procedures and health care	0.994	0.006
M20-M25 Other joint disorders	0.994	0.006
Chapter XII Diseases of the skin and subcutaneous tissue	0.993	0.007
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.993	0.007
Chapter VII Diseases of the eye and adnexa	0.993	0.007
M25 Other joint disorders, not elsewhere classified	0.983	0.017
Chapter XX External causes of morbidity and mortality	0.974	0.026
L80-L99 Other disorders of the skin and subcutaneous tissue	0.972	0.028
Z51 Other medical care	0.965	0.035
Chapter XIV Diseases of the genitourinary system	0.962	0.038
Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified	0.962	0.038
N30-N39 Other diseases of urinary system	0.954	0.046
C50-C50 Malignant neoplasm of breast	0.953	0.047
M25.5 Pain in joint	0.949	0.051
B95-B98 Bacterial, viral and other infectious agents	0.949	0.051
T80-T88 Complications of surgical and medical care, not elsewhere classified	0.946	0.054
M35 Other systemic involvement of connective tissue	0.946	0.054
A30-A49 Other bacterial diseases	0.944	0.056
R50-R69 General symptoms and signs	0.943	0.057
R53 Malaise and fatigue	0.939	0.061
Chapter IX Diseases of the circulatory system	0.936	0.064
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.933	0.067
Z85.3 Personal history of malignant neoplasm of breast	0.931	0.069
C79 Secondary malignant neoplasm of other sites	0.931	0.069
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.930	0.070
N30 Cystitis	0.929	0.071
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.928	0.072
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.928	0.072
B35-B49 Mycoses	0.927	0.073
Chapter VIII Diseases of the ear and mastoid process	0.925	0.075
I20-I25 Ischaemic heart diseases	0.925	0.075
D37-D48 Neoplasms of uncertain or unknown behaviour	0.923	0.077
M25.55 Pain in joint (Pelvic region and thigh)	0.920	0.080
C50 Malignant neoplasm of breast	0.919	0.081
L97 Ulcer of lower limb, not elsewhere classified	0.915	0.085
B96 Other bacterial agents as the cause of diseases classified to other chapters	0.914	0.086
M65-M68 Disorders of synovium and tendon	0.911	0.089
I25 Chronic ischaemic heart disease	0.911	0.089
L20-L30 Dermatitis and eczema	0.907	0.093
M35.3 Polymyalgia rheumatica	0.903	0.097
S80-S89 Injuries to the knee and lower leg	0.900	0.100
H25-H28 Disorders of lens	0.899	0.101
N30.9 Cystitis, unspecified	0.898	0.102
C51-C58 Malignant neoplasms of female genital organs	0.896	0.104
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.893	0.107
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.893	0.107
I21 Acute myocardial infarction	0.892	0.108
D00-D09 In situ neoplasms	0.891	0.109
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.891	0.109
I60-I69 Cerebrovascular diseases	0.889	0.111
Z48 Other surgical follow-up care	0.888	0.112
Z95 Presence of cardiac and vascular implants and grafts	0.887	0.113
Chapter VI Diseases of the nervous system	0.886	0.114
B96.8 Other specified bacterial agents as the cause of diseases classified to other chapters	0.883	0.117
Z92 Personal history of medical treatment	0.882	0.118
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.879	0.121
Z51.1 Chemotherapy session for neoplasm	0.878	0.122
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.873	0.127
Z51.0 Radiotherapy session	0.868	0.132
A49 Bacterial infection of unspecified site	0.868	0.132
Z85.4 Personal history of malignant neoplasm of genital organs	0.867	0.133
I21.0 Acute transmural myocardial infarction of anterior wall	0.865	0.135
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.864	0.136
Z46 Fitting and adjustment of other devices	0.862	0.138
Z85.1 Personal history of malignant neoplasm of trachea, bronchus and lung	0.862	0.138
R30-R39 Symptoms and signs involving the urinary system	0.862	0.138
Z83 Family history of other specific disorders	0.861	0.139
R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis	0.861	0.139
I25.2 Old myocardial infarction	0.858	0.142
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.856	0.144
H43-H45 Disorders of vitreous body and globe	0.856	0.144
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.855	0.145
C50.4 Upper-outer quadrant of breast	0.854	0.146
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.852	0.148
R35 Polyuria	0.851	0.149
H40-H42 Glaucoma	0.849	0.150
L90 Atrophic disorders of skin	0.849	0.151
H30-H36 Disorders of choroid and retina	0.848	0.152
C50.9 Breast, unspecified	0.847	0.153
B15-B19 Viral hepatitis	0.845	0.155
Z45 Adjustment and management of implanted device	0.845	0.155
Z92.3 Personal history of irradiation	0.843	0.157
M25.7 Osteophyte	0.842	0.158
B37 Candidiasis	0.841	0.159
N39 Other disorders of urinary system	0.840	0.160
N60-N64 Disorders of breast	0.840	0.160
H25 Senile cataract	0.838	0.162
H90-H95 Other disorders of ear	0.835	0.165
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts	0.834	0.166
M21 Other acquired deformities of limbs	0.831	0.169
L85 Other epidermal thickening	0.827	0.173
Z95.5 Presence of coronary angioplasty implant and graft	0.823	0.177
C77.2 Intra-abdominal lymph nodes	0.822	0.178
T85 Complications of other internal prosthetic devices, implants and grafts	0.822	0.178
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.821	0.179
N35 Urethral stricture	0.820	0.180
Z96 Presence of other functional implants	0.819	0.181
Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.819	0.181
Z85.2 Personal history of malignant neoplasm of other respiratory and intrathoracic organs	0.818	0.182
N25-N29 Other disorders of kidney and ureter	0.816	0.184
M67 Other disorders of synovium and tendon	0.815	0.185
Z47 Other orthopaedic follow-up care	0.815	0.185
M86-M90 Other osteopathies	0.813	0.187
Z51.2 Other chemotherapy	0.813	0.187
Y84.2 Radiological procedure and radiotherapy	0.813	0.187
H25.1 Senile nuclear cataract	0.813	0.187
L30 Other dermatitis	0.811	0.189
R59 Enlarged lymph nodes	0.810	0.190
I67 Other cerebrovascular diseases	0.809	0.191
Z43 Attention to artificial openings	0.808	0.192
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.807	0.193
Z80 Family history of malignant neoplasm	0.804	0.196
D05 Carcinoma in situ of breast	0.801	0.199
C90 Multiple myeloma and malignant plasma cell neoplasms	0.801	0.199
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.801	0.199
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.800	0.200
M70-M79 Other soft tissue disorders	0.799	0.201
S70-S79 Injuries to the hip and thigh	0.799	0.201
M25.57 Pain in joint (Ankle and foot)	0.797	0.203
Chapter XXII Codes for special purposes	0.797	0.203
S20-S29 Injuries to the thorax	0.796	0.204
M23 Internal derangement of knee	0.794	0.206
Z97 Presence of other devices	0.793	0.207
Z44 Fitting and adjustment of external prosthetic device	0.792	0.207
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.792	0.208
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.792	0.208
G35-G37 Demyelinating diseases of the central nervous system	0.791	0.209
I60 Subarachnoid haemorrhage	0.790	0.210
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.786	0.214
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.786	0.214
B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters	0.786	0.214
D70-D77 Other diseases of blood and blood-forming organs	0.784	0.216
L92 Granulomatous disorders of skin and subcutaneous tissue	0.783	0.217
N10-N16 Renal tubulo-interstitial diseases	0.783	0.217
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.783	0.217
A49.0 Staphylococcal infection, unspecified	0.782	0.218
I69 Sequelae of cerebrovascular disease	0.782	0.218
C77.0 Lymph nodes of head, face and neck	0.782	0.218
L60-L75 Disorders of skin appendages	0.782	0.218
Z95.1 Presence of aortocoronary bypass graft	0.782	0.218
T81 Complications of procedures, not elsewhere classified	0.781	0.219
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.780	0.220
A41 Other septicaemia	0.778	0.222
M25.52 Pain in joint (Upper arm)	0.777	0.223
S83 Dislocation, sprain and strain of joints and ligaments of knee	0.777	0.223
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.776	0.224
B35 Dermatophytosis	0.776	0.224
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.774	0.225
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.774	0.226
C77.1 Intrathoracic lymph nodes	0.773	0.227
Y57 Other and unspecified drugs and medicaments	0.771	0.229
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.771	0.229
B37.9 Candidiasis, unspecified	0.770	0.230
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.768	0.232
Y41 Other systemic anti-infectives and antiparasitics	0.768	0.232
C79.2 Secondary malignant neoplasm of skin	0.768	0.232
N30.8 Other cystitis	0.768	0.232
M25.9 Joint disorder, unspecified	0.768	0.232
R61 Hyperhidrosis	0.767	0.233
M25.4 Effusion of joint	0.766	0.234
C01 Malignant neoplasm of base of tongue	0.766	0.234
H18 Other disorders of cornea	0.765	0.235
Y83.1 Surgical operation with implant of artificial internal device	0.764	0.236
L00-L08 Infections of the skin and subcutaneous tissue	0.764	0.236
M60-M63 Disorders of muscles	0.763	0.237
C43-C44 Melanoma and other malignant neoplasms of skin	0.763	0.237
N00-N08 Glomerular diseases	0.762	0.238
Z41 Procedures for purposes other than remedying health state	0.761	0.239
Y84.6 Urinary catheterisation	0.761	0.239
L90.5 Scar conditions and fibrosis of skin	0.761	0.239
Z48.0 Attention to surgical dressings and sutures	0.760	0.240
C56 Malignant neoplasm of ovary	0.759	0.241
R80-R82 Abnormal findings on examination of urine, without diagnosis	0.759	0.241
R87 Abnormal findings in specimens from female genital organs	0.758	0.242
R50 Fever of unknown origin	0.758	0.242
C81 Hodgkin's disease	0.758	0.242
H43 Disorders of vitreous body	0.758	0.242
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.757	0.242
I25.8 Other forms of chronic ischaemic heart disease	0.757	0.243
T79-T79 Certain early complications of trauma	0.757	0.243
Z54 Convalescence	0.756	0.244
S10-S19 Injuries to the neck	0.753	0.247
D69 Purpura and other haemorrhagic conditions	0.753	0.247
M25.8 Other specified joint disorders	0.752	0.248
I21.9 Acute myocardial infarction, unspecified	0.752	0.248
D05.1 Intraductal carcinoma in situ	0.751	0.249
H65-H75 Diseases of middle ear and mastoid	0.751	0.249
S90-S99 Injuries to the ankle and foot	0.750	0.250
Chapter V Mental and behavioural disorders	0.749	0.251
C54 Malignant neoplasm of corpus uteri	0.749	0.251
N39.3 Stress incontinence	0.748	0.252
Z42 Follow-up care involving plastic surgery	0.747	0.253
Y44 Agents primarily affecting blood constituents	0.747	0.253
H40 Glaucoma	0.747	0.253
M67.8 Other specified disorders of synovium and tendon	0.747	0.253
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.747	0.253
S50-S59 Injuries to the elbow and forearm	0.742	0.258
L30.9 Dermatitis, unspecified	0.742	0.258
Z96.1 Presence of intraocular lens	0.740	0.260
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.739	0.260
L98.8 Other specified disorders of skin and subcutaneous tissue	0.739	0.261
H33 Retinal detachments and breaks	0.739	0.261
Y83.6 Removal of other organ (partial) (total)	0.739	0.261
N30.2 Other chronic cystitis	0.739	0.261
B18 Chronic viral hepatitis	0.738	0.262
Z45.0 Adjustment and management of cardiac pacemaker	0.736	0.264
D03 Melanoma in situ	0.736	0.264
C50.5 Lower-outer quadrant of breast	0.736	0.264
S30 Superficial injury of abdomen, lower back and pelvis	0.735	0.265
M45-M49 Spondylopathies	0.735	0.265
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.735	0.265
H46-H48 Disorders of optic nerve and visual pathways	0.734	0.265
R58 Haemorrhage, not elsewhere classified	0.734	0.266
M91-M94 Chondropathies	0.734	0.266
N64 Other disorders of breast	0.734	0.266
H80-H83 Diseases of inner ear	0.734	0.266
A40 Streptococcal septicaemia	0.734	0.266
X20-X29 Contact with venomous animals and plants	0.733	0.267
B98 Other specified infectious agents as the cause of diseases classified to other chapters	0.733	0.267
M25.77 Osteophyte (Ankle and foot)	0.733	0.267
C83 Diffuse non-Hodgkin's lymphoma	0.732	0.267
H53-H54 Visual disturbances and blindness	0.732	0.268
I25.5 Ischaemic cardiomyopathy	0.731	0.269
M35.0 Sicca syndrome [Sjogren]	0.731	0.269
T93 Sequelae of injuries of lower limb	0.729	0.271
Z52 Donors of organs and tissues	0.729	0.271
T83 Complications of genito-urinary prosthetic devices, implants and grafts	0.729	0.271
R90-R94 Abnormal findings on diagnostic imaging and in function studies, without diagnosis	0.728	0.272
L29 Pruritus	0.728	0.272
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.728	0.272
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.727	0.273
Z48.9 Surgical follow-up care, unspecified	0.727	0.273
C10 Malignant neoplasm of oropharynx	0.727	0.273
Z96.7 Presence of other bone and tendon implants	0.727	0.273
C79.8 Secondary malignant neoplasm of other specified sites	0.727	0.273
N35.9 Urethral stricture, unspecified	0.725	0.275
Y40 Systemic antibiotics	0.724	0.276
H92 Otalgia and effusion of ear	0.722	0.278
G35 Multiple sclerosis	0.722	0.278
C80 Malignant neoplasm without specification of site	0.721	0.279
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts	0.720	0.280
L89 Decubitus ulcer	0.720	0.280
S82 Fracture of lower leg, including ankle	0.719	0.281
T80 Complications following infusion, transfusion and therapeutic injection	0.719	0.281
I67.1 Cerebral aneurysm, nonruptured	0.718	0.282
Q00-Q07 Congenital malformations of the nervous system	0.718	0.282
R59.0 Localised enlarged lymph nodes	0.718	0.282
C78.0 Secondary malignant neoplasm of lung	0.718	0.282
R69 Unknown and unspecified causes of morbidity	0.718	0.282
Y43 Primarily systemic agents	0.717	0.283
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.717	0.283
C40-C41 Malignant neoplasms of bone and articular cartilage	0.717	0.283
Z40 Prophylactic surgery	0.717	0.283
Z85.0 Personal history of malignant neoplasm of digestive organs	0.716	0.283
Z85.9 Personal history of malignant neoplasm, unspecified	0.716	0.283
Z89 Acquired absence of limb	0.716	0.283
Z84 Family history of other conditions	0.716	0.283
Z81 Family history of mental and behavioural disorders	0.716	0.283
Z92.0 Personal history of contraception	0.716	0.284
I25.1 Atherosclerotic heart disease	0.715	0.285
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.715	0.285
M00-M03 Infectious arthropathies	0.714	0.286
M65 Synovitis and tenosynovitis	0.714	0.286
S81 Open wound of lower leg	0.714	0.286
T86 Failure and rejection of transplanted organs and tissues	0.714	0.286
Z51.5 Palliative care	0.714	0.286
B99-B99 Other infectious diseases	0.714	0.286
B90-B94 Sequelae of infectious and parasitic diseases	0.714	0.286
B85-B89 Pediculosis, acariasis and other infestations	0.714	0.286
B65-B83 Helminthiases	0.714	0.286
B50-B64 Protozoal diseases	0.714	0.286
B20-B24 Human immunodeficiency virus [HIV] disease	0.714	0.286
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.714	0.286
A80-A89 Viral infections of the central nervous system	0.714	0.286
A75-A79 Rickettsioses	0.714	0.286
A70-A74 Other diseases caused by chlamydiae	0.714	0.286
A65-A69 Other spirochaetal diseases	0.714	0.286
A20-A28 Certain zoonotic bacterial diseases	0.714	0.286
A15-A19 Tuberculosis	0.714	0.286
T33-T35 Frostbite	0.713	0.287
T26-T28 Burns and corrosions confined to eye and internal organs	0.713	0.287
T20-T25 Burns and corrosions of external body surface, specified by site	0.713	0.287
T00-T07 Injuries involving multiple body regions	0.713	0.287
W20-W49 Exposure to inanimate mechanical forces	0.713	0.287
A49.8 Other bacterial infections of unspecified site	0.713	0.287
Z49 Care involving dialysis	0.713	0.287
M36 Systemic disorders of connective tissue in diseases classified elsewhere	0.713	0.287
M34 Systemic sclerosis	0.713	0.287
M33 Dermatopolymyositis	0.713	0.287
M32 Systemic lupus erythematosus	0.713	0.287
M30 Polyarteritis nodosa and related conditions	0.713	0.287
C77.3 Axillary and upper limb lymph nodes	0.713	0.287
M25.51 Pain in joint (Shoulder region)	0.713	0.287
L10-L14 Bullous disorders	0.712	0.288
C76 Malignant neoplasm of other and ill-defined sites	0.712	0.288
X60-X84 Intentional self-harm	0.712	0.288
R47-R49 Symptoms and signs involving speech and voice	0.711	0.289
H10-H13 Disorders of conjunctiva	0.711	0.289
N32 Other disorders of bladder	0.710	0.290
M22 Disorders of patella	0.710	0.290
S60-S69 Injuries to the wrist and hand	0.710	0.290
I25.9 Chronic ischaemic heart disease, unspecified	0.709	0.291
M25.6 Stiffness of joint, not elsewhere classified	0.709	0.291
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.708	0.292
L50-L54 Urticaria and erythema	0.708	0.292
R54 Senility	0.708	0.292
Z46.8 Fitting and adjustment of other specified devices	0.707	0.293
R70-R79 Abnormal findings on examination of blood, without diagnosis	0.707	0.293
M21.4 Flat foot [pes planus] (acquired)	0.707	0.293
C90.0 Multiple myeloma	0.707	0.293
Z88 Personal history of allergy to drugs, medicaments and biologocal substances	0.706	0.294
I25.3 Aneurysm of heart	0.705	0.295
L91 Hypertrophic disorders of skin	0.705	0.295
M25.3 Other instability of joint	0.704	0.295
M25.2 Flail joint	0.704	0.295
M25.1 Fistula of joint	0.704	0.295
M25.0 Haemarthrosis	0.704	0.295
G62 Other polyneuropathies	0.704	0.296
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.703	0.297
T81.0 Haemorrhage and haematoma complicating a procedure, not elsewhere classified	0.703	0.297
Z80.3 Family history of malignant neoplasm of breast	0.702	0.298
M80-M85 Disorders of bone density and structure	0.702	0.298
L84 Corns and callosities	0.702	0.298
H20 Iridocyclitis	0.702	0.298
Z51.8 Other specified medical care	0.701	0.299
I60.9 Subarachnoid haemorrhage, unspecified	0.700	0.300
M79 Other soft tissue disorders, not elsewhere classified	0.699	0.301
T15-T19 Effects of foreign body entering through natural orifice	0.699	0.301
L85.9 Epidermal thickening, unspecified	0.699	0.301
R39 Other symptoms and signs involving the urinary system	0.698	0.301
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.698	0.302
Y35-Y36 Legal intervention and operations of war	0.698	0.302
Y10-Y34 Event of undetermined intent	0.698	0.302
Y00-Y09 Assault	0.698	0.302
X85-X99 Assault	0.698	0.302
X58-X59 Accidental exposure to other and unspecified factors	0.698	0.302
X50-X57 Overexertion, travel and privation	0.698	0.302
X40-X49 Accidental poisoning by and exposure to noxious substances	0.698	0.302
X30-X39 Exposure to forces of nature	0.698	0.302
X10-X19 Contact with heat and hot substances	0.698	0.302
X00-X09 Exposure to smoke, fire and flames	0.698	0.302
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.698	0.302
W75-W84 Other accidental threats to breathing	0.698	0.302
W65-W74 Accidental drowning and submersion	0.698	0.302
W50-W64 Exposure to animate mechanical forces	0.698	0.302
V98-V99 Other and unspecified transport accidents	0.698	0.302
V95-V97 Air and space transport accidents	0.698	0.302
V90-V94 Water transport accidents	0.698	0.302
V80-V89 Other land transport accidents	0.698	0.302
V70-V79 Bus occupant injured in transport accident	0.698	0.302
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.698	0.302
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.698	0.302
V40-V49 Car occupant injured in transport accident	0.698	0.302
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.698	0.302
V01-V09 Pedestrian injured in transport accident	0.698	0.302
M25.53 Pain in joint (Forearm)	0.698	0.302
N28 Other disorders of kidney and ureter, not elsewhere classified	0.698	0.302
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.697	0.303
L95 Vasculitis limited to skin, not elsewhere classified	0.697	0.303
L94 Other localised connective tissue disorders	0.697	0.303
L93 Lupus erythematosus	0.697	0.303
L87 Transepidermal elimination disorders	0.697	0.303
L88 Pyoderma gangrenosum	0.697	0.303
L86 Keratoderma in diseases classified elsewhere	0.697	0.303
L83 Acanthosis nigricans	0.697	0.303
L80 Vitiligo	0.697	0.303
N62 Hypertrophy of breast	0.697	0.303
M66 Spontaneous rupture of synovium and tendon	0.696	0.304
L40-L45 Papulosquamous disorders	0.696	0.304
D37.0 Lip, oral cavity and pharynx	0.696	0.304
C60-C63 Malignant neoplasms of male genital organs	0.695	0.305
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.693	0.307
Z83.5 Family history of eye and ear disorders	0.693	0.307
R57 Shock, not elsewhere classified	0.693	0.307
V10-V19 Pedal cyclist injured in transport accident	0.692	0.307
Z51.9 Medical care, unspecified	0.692	0.308
Z51.6 Desensitisation to allergens	0.692	0.308
H91 Other hearing loss	0.692	0.308
Z51.3 Blood transfusion without reported diagnosis	0.690	0.310
R95-R99 Ill-defined and unknown causes of mortality	0.689	0.311
R52 Pain, not elsewhere classified	0.689	0.311
T85.3 Mechanical complication of other ocular prosthetic devices, imnplants and grafts	0.688	0.312
Q50-Q56 Congenital malformations of genital organs	0.688	0.312
D09 Carcinoma in situ of other and unspecified sites	0.687	0.313
H55-H59 Other disorders of eye and adnexa	0.687	0.313
Y52 Agents primarily affecting the cardiovascular system	0.686	0.314
T85.4 Mechanical complication of breast prosthesis and implant	0.685	0.315
D69.3 Idiopathic thrombocytopenic purpura	0.685	0.315
R87.6 Abnormal cytological findings	0.685	0.315
L27 Dermatitis due to substances taken internally	0.684	0.316
M90 Osteopathies in diseases classified elsewhere	0.684	0.316
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.684	0.316
N37 Urethral disorders in diseases classified elsewhere	0.684	0.316
N34 Urethritis and urethral syndrome	0.684	0.316
N33 Bladder disorders in diseases classified elsewhere	0.684	0.316
M70 Soft tissue disorders related to use, overuse and pressure	0.683	0.317
M24 Other specific joint derangements	0.682	0.317
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.682	0.317
D45 Polycythaemia vera	0.682	0.318
A50-A64 Infections with a predominantly sexual mode of transmission	0.682	0.318
Z46.6 Fitting and adjustment of urinary device	0.682	0.318
M25.59 Pain in joint (Site unspecified)	0.681	0.319
M25.58 Pain in joint (Other)	0.681	0.319
D80-D89 Certain disorders involving the immune mechanism	0.680	0.320
Z94 Transplanted organ and tissue status	0.680	0.320
T87 Complications peculiar to reattachment and amputation	0.679	0.321
M35.9 Systemic involvement of connective tissue, unspecified	0.678	0.322
M35.8 Other specified systemic involvement of connective tissue	0.678	0.322
M35.7 Hypermobility syndrome	0.678	0.322
M35.6 Relapsing panniculitis [Weber-Christian]	0.678	0.322
M35.5 Multifocal fibrosclerosis	0.678	0.322
M35.4 Diffuse (eosinophilic) fasciitis	0.678	0.322
M35.2 Behcet's disease	0.678	0.322
M35.1 Other overlap syndromes	0.678	0.322
T85.8 Other complications of internal prosthetic devices, implants and grafts, not elsewhere classified	0.677	0.323
A48 Other bacterial diseases, not elsewhere classified	0.677	0.323
A44 Bartonellosis	0.677	0.323
A43 Nocardiosis	0.677	0.323
A42 Actinomycosis	0.677	0.323
A39 Meningococcal infection	0.677	0.323
A37 Whooping cough	0.677	0.323
A36 Diphtheria	0.677	0.323
A32 Listeriosis	0.677	0.323
A31 Infection due to other mycobacteria	0.677	0.323
A30 Leprosy [Hansen's disease]	0.677	0.323
A46 Erysipelas	0.677	0.323
A38 Scarlet fever	0.677	0.323
A35 Other tetanus	0.677	0.323
A34 Obstetrical tetanus	0.677	0.323
A33 Tetanus neonatorum	0.677	0.323
H34 Retinal vascular occlusions	0.676	0.323
L73 Other follicular disorders	0.676	0.324
R65 Systemic Inflammatory Response Syndrome [SIRS]	0.676	0.324
R62 Lack of expected normal physiological development	0.676	0.324
R64 Cachexia	0.676	0.324
Z92.4 Personal history of major surgery, not elsewhere classified	0.676	0.324
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.675	0.325
Z70-Z76 Persons encountering health services in other circumstances	0.674	0.326
G20-G26 Extrapyramidal and movement disorders	0.674	0.326
S40-S49 Injuries to the shoulder and upper arm	0.674	0.326
Y54.3 Benzothiadiazine derivatives	0.674	0.326
Z47.0 Follow-up care involving removal of fracture plate and other internal fixation device	0.673	0.327
C44 Other malignant neoplasms of skin	0.673	0.327
R84 Abnormal findings in specimens from respiratory organs and thorax	0.673	0.327
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.672	0.328
Q80-Q89 Other congenital malformations	0.671	0.329
I00-I02 Acute rheumatic fever	0.671	0.329
Z43.2 Attention to ileostomy	0.671	0.329
Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung	0.670	0.330
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.670	0.330
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.669	0.331
C95 Leukaemia of unspecified cell type	0.669	0.331
C94 Other leukaemias of specified cell type	0.669	0.331
C93 Monocytic leukaemia	0.669	0.331
C88 Malignant immunoproliferative diseases	0.669	0.331
C86 Other specified types of T/NK-cell lymphoma	0.669	0.331
C84 Peripheral and cutaneous T-cell lymphomas	0.669	0.331
Z88.7 Personal history of allergy to serum and vaccine	0.669	0.331
T66-T78 Other and unspecified effects of external causes	0.669	0.331
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.669	0.331
G00-G09 Inflammatory diseases of the central nervous system	0.669	0.331
S32 Fracture of lumbar spine and pelvis	0.669	0.331
C79.9 Secondary malignant neoplasm, unspecified site	0.668	0.332
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue	0.668	0.332
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.668	0.332
C79.6 Secondary malignant neoplasm of ovary	0.667	0.333
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.667	0.333
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.667	0.333
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.667	0.333
C02 Malignant neoplasm of other and unspecified parts of tongue	0.667	0.333
C85.1 B-cell lymphoma, unspecified	0.667	0.333
N99-N99 Other disorders of the genitourinary system	0.666	0.333
N30.4 Irradiation cystitis	0.666	0.334
N30.0 Acute cystitis	0.666	0.334
Y59 Other and unspecified vaccines and biological substances	0.666	0.334
Y58 Bacterial vaccines	0.666	0.334
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.666	0.334
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.666	0.334
Y53 Agents primarily affecting the gastro-intestinal system	0.666	0.334
Y50 Central nervous system stimulants, not elsewhere classified	0.666	0.334
Y49 Psychotropic drugs, not elsewhere classified	0.666	0.334
Y48 Anaesthetics and therapeutic gases	0.666	0.334
Y47 Sedatives, hypnotics and antianxiety drugs	0.666	0.334
Y46 Antiepileptics and anti-Parkinsonism drugs	0.666	0.334
C77.8 Lymph nodes of multiple regions	0.665	0.335
C77.4 Inguinal and lower limb lymph nodes	0.665	0.335
I69.0 Sequelae of subarachnoid haemorrhage	0.665	0.335
B48 Other mycoses, not elsewhere classified	0.664	0.336
B47 Mycetoma	0.664	0.336
B46 Zygomycosis	0.664	0.336

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations